These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 36596539)

  • 21. Advances in microfluidic in vitro systems for neurological disease modeling.
    Holloway PM; Willaime-Morawek S; Siow R; Barber M; Owens RM; Sharma AD; Rowan W; Hill E; Zagnoni M
    J Neurosci Res; 2021 May; 99(5):1276-1307. PubMed ID: 33583054
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ABC transporters and drug efflux at the blood-brain barrier.
    Shen S; Zhang W
    Rev Neurosci; 2010; 21(1):29-53. PubMed ID: 20458886
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Current Status of
    Shah B; Dong X
    Curr Drug Deliv; 2022; 19(10):1034-1046. PubMed ID: 35240972
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Advances in microphysiological blood-brain barrier (BBB) models towards drug delivery.
    Lee CS; Leong KW
    Curr Opin Biotechnol; 2020 Dec; 66():78-87. PubMed ID: 32711361
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structural pathways for macromolecular and cellular transport across the blood-brain barrier during inflammatory conditions. Review.
    Lossinsky AS; Shivers RR
    Histol Histopathol; 2004 Apr; 19(2):535-64. PubMed ID: 15024715
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Utilizing microphysiological systems and induced pluripotent stem cells for disease modeling: a case study for blood brain barrier research in a pharmaceutical setting.
    Fabre KM; Delsing L; Hicks R; Colclough N; Crowther DC; Ewart L
    Adv Drug Deliv Rev; 2019 Feb; 140():129-135. PubMed ID: 30253201
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The Blood-Brain Barrier (BBB) and in vitro BBB Models].
    Takeshita Y; Kanda T
    Brain Nerve; 2015 Aug; 67(8):1035-42. PubMed ID: 26241364
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Models of the blood-brain barrier using iPSC-derived cells.
    Delsing L; Herland A; Falk A; Hicks R; Synnergren J; Zetterberg H
    Mol Cell Neurosci; 2020 Sep; 107():103533. PubMed ID: 32717317
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of flow on targeting and penetration of angiopep-decorated nanoparticles in a microfluidic model blood-brain barrier.
    Papademetriou I; Vedula E; Charest J; Porter T
    PLoS One; 2018; 13(10):e0205158. PubMed ID: 30300391
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Three-dimensional co-culture of blood-brain barrier-composing cells in a culture insert with a collagen vitrigel membrane.
    Shima A; Nagata S; Takeuchi S
    In Vitro Cell Dev Biol Anim; 2020 Aug; 56(7):500-504. PubMed ID: 32820386
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Blood-brain barrier models: in vitro to in vivo translation in preclinical development of CNS-targeting biotherapeutics.
    Stanimirovic DB; Bani-Yaghoub M; Perkins M; Haqqani AS
    Expert Opin Drug Discov; 2015 Feb; 10(2):141-55. PubMed ID: 25388782
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recent progress and new challenges in modeling of human pluripotent stem cell-derived blood-brain barrier.
    Yan L; Moriarty RA; Stroka KM
    Theranostics; 2021; 11(20):10148-10170. PubMed ID: 34815809
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neurovascular unit on a chip: implications for translational applications.
    Alcendor DJ; Block FE; Cliffel DE; Daniels JS; Ellacott KL; Goodwin CR; Hofmeister LH; Li D; Markov DA; May JC; McCawley LJ; McLaughlin B; McLean JA; Niswender KD; Pensabene V; Seale KT; Sherrod SD; Sung HJ; Tabb DL; Webb DJ; Wikswo JP
    Stem Cell Res Ther; 2013; 4 Suppl 1(Suppl 1):S18. PubMed ID: 24564885
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High-Throughput Screening for Identification of Blood-Brain Barrier Integrity Enhancers: A Drug Repurposing Opportunity to Rectify Vascular Amyloid Toxicity.
    Qosa H; Mohamed LA; Al Rihani SB; Batarseh YS; Duong QV; Keller JN; Kaddoumi A
    J Alzheimers Dis; 2016 Jul; 53(4):1499-516. PubMed ID: 27392852
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Numerical approach-based simulation to predict cerebrovascular shear stress in a blood-brain barrier organ-on-a-chip.
    Jeong S; Seo JH; Garud KS; Park SW; Lee MY
    Biosens Bioelectron; 2021 Jul; 183():113197. PubMed ID: 33819903
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New experimental models of the blood-brain barrier for CNS drug discovery.
    Kaisar MA; Sajja RK; Prasad S; Abhyankar VV; Liles T; Cucullo L
    Expert Opin Drug Discov; 2017 Jan; 12(1):89-103. PubMed ID: 27782770
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In Vitro Models of the Blood-Brain Barrier.
    Neuhaus W
    Handb Exp Pharmacol; 2021; 265():75-110. PubMed ID: 32562060
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Blood-brain barrier drug delivery of IgG fusion proteins with a transferrin receptor monoclonal antibody.
    Pardridge WM
    Expert Opin Drug Deliv; 2015 Feb; 12(2):207-22. PubMed ID: 25138991
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Permeability of PEGylated immunoarsonoliposomes through in vitro blood brain barrier-medulloblastoma co-culture models for brain tumor therapy.
    Al-Shehri A; Favretto ME; Ioannou PV; Romero IA; Couraud PO; Weksler BB; Parker TL; Kallinteri P
    Pharm Res; 2015 Mar; 32(3):1072-83. PubMed ID: 25236341
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Brain-to-blood transporters for endogenous substrates and xenobiotics at the blood-brain barrier: an overview of biology and methodology.
    Terasaki T; Ohtsuki S
    NeuroRx; 2005 Jan; 2(1):63-72. PubMed ID: 15717058
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.